Evidence map›Paper›PMID 42811068›Full record

ArticleBone marrow transplantation2026

Analytical variability in chimerism testing may influence longitudinal clinical interpretation after allogeneic hematopoietic cell transplantation.

Reut Hod Dvorai, Alan M Sanfilippo, Anna L Greenshields, Ahmed Mostafa, William Hoffman, Rajesh Parmar, Neng Yu, Ketevan Gendzekhadze, Lee Ann Baxter-Lowe, Olga A Timofeeva

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Reut Hod Dvorai *Department of Pathology, SUNY Upstate Medical University, Syracuse, NY, USA.ORCID http://orcid.org/0000-0001-6748-5733
Alan M Sanfilippo *Piedmont Transplant Institute, Piedmont Healthcare Inc., Atlanta, GA, USA.ORCID http://orcid.org/0009-0001-2681-8930
Anna L GreenshieldsDepartment of Pathology, Dalhousie University, Halifax, NS, Canada.
Ahmed MostafaDepartment of Pathology and Laboratory Medicine, Saskatchewan Health Authority, Saskatoon, SK, Canada.ORCID http://orcid.org/0000-0001-5672-0144
William HoffmanTransplant Nephrology, UPMC Harrisburg, Harrisburg, PA, USA.ORCID http://orcid.org/0000-0003-3858-2862
Rajesh ParmarUCLA Immunogenetics Center, Department of Pathology and Laboratory Medicine, UCLA Health, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-6122-4345
Neng YuUMass Chan Medical School, Worcester, MA, USA.
Ketevan GendzekhadzeDepartment of Hematology & Hematopoietic Cell Transplantation, Histocompatibility (HLA) & Immunogenetics Laboratory, City of Hope, Irwindale, CA, USA.
Lee Ann Baxter-LoweDepartment of Pathology and Laboratory Medicine, Children's Hospital of Los Angeles, Los Angeles, CA, USA.
Olga A TimofeevaUCLA Immunogenetics Center, Department of Pathology and Laboratory Medicine, UCLA Health, Los Angeles, CA, USA. otimofeeva@mednet.ucla.edu.ORCID http://orcid.org/0000-0002-9886-6683

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42811068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.